Patents by Inventor Arumugam JAYAKUMAR

Arumugam JAYAKUMAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260102458
    Abstract: Described herein is a method of treating or preventing a long term coronavirus infection in a subject in need thereof comprising a therapeutically effective amount of a peptide, wherein the formulation comprises peptides having an amino acid sequence comprising: (M)nVR(I/L)KP(G/A)(S/T)(A/G)NKP(S/T)(D/E)D, (SEQ ID NO: 20), where n=0 or 1.
    Type: Application
    Filed: May 20, 2025
    Publication date: April 16, 2026
    Inventors: Michael Paidas, Arumugam Jayakumar
  • Publication number: 20240293501
    Abstract: This invention provides reagents, pharmaceutical formulations comprising such reagents, and methods for preventing and treating viral infections, specifically coronavirus infections, and in particular infections in humans with COVID-19.
    Type: Application
    Filed: June 21, 2021
    Publication date: September 5, 2024
    Inventors: Michael J. Paidas, Arumugam Jayakumar
  • Patent number: 10703721
    Abstract: In one aspect, the present disclosure provides caffeic acid derivatives of the formula: wherein the variables are as defined herein. In another aspect, the present disclosure provides pharmaceutical compositions and methods of using of the compounds disclosed herein, including for the treatment of cancer.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: July 7, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Waldemar Priebe, Stanislaw Skora, Izabela Fokt, Rafal Zielinski, Arumugam Jayakumar, Radjendirane Venugopal
  • Publication number: 20190177276
    Abstract: In one aspect, the present disclosure provides caffeic acid derivatives of the formula: wherein the variables are as defined herein. In another aspect, the present disclosure provides pharmaceutical compositions and methods of using of the compounds disclosed herein, including for the treatment of cancer.
    Type: Application
    Filed: November 9, 2018
    Publication date: June 13, 2019
    Inventors: Waldemar PRIEBE, Stanislaw SKORA, Izabela FOKT, Rafal ZIELINSKI, Arumugam JAYAKUMAR, Radjendirane VENUGOPAL